Shilpa Medicare Limited (SHILPAMED.BO) Seasonal Returns Chart - Yahoo Finance
NiveshIQ
NSE: SHILPAMED · Healthcare
Shilpa Medicare Ltd.
₹924.55▼ ₹31.05 (-3.25%)
Price Chart · Daily closes
1Y
6M
3M
1M
1W
1D
⚡ Intelligence Signals
5 active
🟢 Bullish Earnings Catalyst
📊 RS Laggard (5D)
🔄 Sector Sweep
⚡ Signals Aligned
📉 Pullback
NiveshIQ has detected 5 active signals on SHILPAMED. Sign up free to see what each signal means and how it affects the stock.
Unlock signals — freeExpected Move
1D / 1W / 1M range derived from news, fundamentals & technicals
1 Day
±1.8%
1 Week
±4.2%
1 Month
±9.6%
Confidence Score
Based on historical directional & magnitude accuracy for this stock
74
/ 100
About Shilpa Medicare Ltd.
Shilpa Medicare Limited is a specialty pharmaceutical company that manufactures active pharmaceutical ingredients (APIs), finished dosage forms, biosimilars, and offers contract development and manufacturing (CDMO) services across India, the United States, and Europe. In FY27 Q1, the company reported revenue of ₹1,683 crore and net income of ₹297 crore, driven largely by high-margin oncology APIs such as anastrozole, axitinib, and lenalidomide. Recent developments include a strategic partnership with Swiss firm NXI Therapeutics to develop a new chemical entity (NCE), expanding its pipeline and international collaboration footprint. The company’s competitive position is reinforced by its diversified product portfolio, strong quality compliance, and a growing CDMO segment that attracts globa
Financial Highlights
| Metric | FY24 | FY25 | FY26 |
|---|---|---|---|
| Revenue | ₹1,152 Cr +9.66% | ₹1,286 Cr +11.71% | ₹1,539 Cr +19.62% |
| EBITDA Margin | 21.23% | 24.65% | 28.25% |
| Net Profit | ₹31.87 Cr -203.20% | ₹78.29 Cr +145.63% | ₹243.33 Cr +210.79% |
| EPS | ₹3.67 | ₹8.04 | ₹12.44 |
Annual figures in Indian Rupees (Crores). Source: company filings (NSE).
Recent News
Shilpa Medicare SHILPAMED Q2 FY27 Earnings Call Nov 2026
Shilpa Medicare SHILPAMED Q2 FY27 Earnings Call Nov 2026
🔒
+ 3 more stories about Shilpa Medicare Ltd.
Full news feed with AI impact summaries, synced in real time.
Sign up free — it's instantStrategic Outlook
- Q1FY27 results: revenue ₹466 Cr, PAT ₹101 Cr, EPS ₹5.16, EBITDA margin 29.9%. Growth context: revenue QoQ +6.6%, PAT QoQ +56.5%. Street verdict: strong beat, revenue surprise +1.3%, PAT surprise +29.0%.
Patient volumes, occupancy, ARPOB/ARPO, case mix, and bed‑capacity ramp‑up continue to be the primary growth levers over...
FY26 (last completed FY): revenue ₹1, 539 Cr, PAT ₹214 Cr, EBITDA margin 28.9%, EPS ₹12.44. Year-on-year: revenue YoY +1...
🔒
+ 3 more outlook points
Growth drivers, key risks, and upcoming catalysts — unlocked free.
Sign up free — it's instantMore Healthcare stocks
QMS Medical Allied Services Ltd.Rainbow Childrens Medicare Ltd.Rubicon Research Ltd.Sai Life Sciences Ltd.Sanofi India Ltd.Senores Pharmaceuticals Ltd.Strides Pharma Science Ltd.Sun Pharma Advanced Research Company Ltd.Sun Pharmaceutical Industries Ltd.Supriya Lifescience Ltd.Suven Life Sciences Ltd.Syngene International Ltd.
Everything you unlock with a free account
⚡Intelligence Signals — AI-detected patterns across news, earnings & technicals
📈Price Chart — 1D to 1Y daily closes for SHILPAMED
🎯Expected Move — 1D / 1W / 1M range from news, fundamentals & technicals
🧠Confidence Score — Historical directional & magnitude accuracy for this stock
🎙Analyst Target Price — Consensus target with buy / hold / sell breakdown
📰Full News Feed — All stories synced in real time with AI impact summaries
🔭Strategic Outlook — Growth drivers, risks & upcoming catalysts
📊Watchlist & Portfolio — Track SHILPAMED alongside your other holdings
Unlock full SHILPAMED research — free
No credit card · No trial · Always free to start
Frequently Asked Questions
What AI signals does NiveshIQ provide for Shilpa Medicare Ltd.?
NiveshIQ detects active intelligence signals for Shilpa Medicare Ltd. (SHILPAMED) — including earnings catalysts, relative strength patterns, sector sweeps, and pullback setups. It also shows an Expected Move (1D/1W/1M range based on news, fundamentals and technicals) and a Confidence Score based on historical directional and magnitude accuracy. These are exclusive to NiveshIQ.
What are the key financials for Shilpa Medicare Ltd.?
Shilpa Medicare Ltd. operates in the Healthcare sector with a market capitalisation of ₹848,825.1L Cr. Revenue, net profit, EPS and EBITDA margins across the last three annual periods are shown above, sourced from BSE filings.
Does NiveshIQ provide investment advice?
No. NiveshIQ provides educational market intelligence and research context, not investment advice or buy/sell recommendations.